Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Yigit DUZKOYLU
The subject of our research is whether serum apolipoprotein levels can be a predictive value for weight loss in patients who will undergo sleeve gastrectomy due to morbid obesity. Our aim is to determine a cut-off value for patients who benefit most from bariatric surgery based on preoperative serum apolipoprotein levels. By including this value among the surgical indications, we plan to direct patients less likely to benefit from surgery to conservative approaches.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged 18 to 75
International Classification of Diseases (ICD) code E66 diagnosis (obesity)
Patients who have given consent for sleeve gastrectomy
Patients who are suitable for general anesthesia
You may not be if
Patients who did not give consent to be included in the study
Patients who are scheduled for surgery other than sleeve gastrectomy
